Results revealed the 6,000 people who received the vaccine were virus-free 10 days later (Photo: Frederick Murphy/CDC/PAPA)

An experimental vaccine that protects against the deadly Ebola virus could be available by 2018.

Early trials conducted in Guinea, one of the West African countries most affected b of Ebola show it offers 100% protection.

The vaccine is now being fast-tracked for regulatory approval.

Manufacturer Merck has made 300,000 doses of the rVSV-ZEBOV vaccine available for use should another outbreak of Ebola strike again.

Results, published in The Lancet this week, revealed that of nearly 6,000 people receiving the vaccine, all were free of the virus 10 days later.

The children have lived through a horrific period on their country’s history (Photo: Simon Coley)

In a group of the same size not vaccinated, 23 later went on to develop the potentially lethal disease.

Only one person who was vaccinated had a serious side effect that the researchers think was caused by the jab.

They suffered very high temperature but made a full recovery.

However it is not yet known how effective the vaccine will work on children who were not used in the trial.

The director of British-based medical research institute the Wellcome Trust described the findings as “remarkable”.

Jeremy Farrar said: “Had a vaccine been available earlier in the Ebola epidemic, thousands of lives might have been saved.

Video thumbnail, Ebola is god’s judgement on America

“We have to get ahead of the curve and make promising diagnostics, drugs and vaccines for diseases we know could be a threat in the future.”

The trial was led by the World Health Organization (WHO), working with Guinea’s health ministry and international groups.

The WHO’s Marie-Paule Kieny said the results could help combat future outbreaks.

“While these compelling results come too late for those who lost their lives during West Africa’s Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenceless,”

Other drug companies are developing different Ebola vaccines that could be used in the future too.

The Ebola virus was first identified in 1976 but the recent outbreak in West Africa, which killed more than 11,000 people, highlighted the need for a vaccine.

The outbreak began in Guinea in 2013 and spread to Liberia and Sierra Leone.